ReNerve Ltd. is a medical device company focused on the repair of peripheral nerve injuries. The firm is focused on commercializing medical devices and tissue engineering products that address significant unmet needs in peripheral nerve damage patients. The company is also developing tissue-based products for peripheral nerve repair and replacement and other related soft tissue surgical procedures. The company is focused on developing products that accelerate tissue regeneration while preventing scarring and negative inflammatory responses. Its products include NervAlign Nerve Cuff, NervAlign Nerve Graft and NervAlign Bionic Nerve. NervAlign Nerve Cuff is a soft, tissue compatible protective wrap used to protect repaired injured nerves. The company consists of a pliable scaffolding material that can be wrapped around the nerve, protecting surgical repairs and conforming to the nerve’s final shape, allowing regeneration to occur.
Follow-Up Questions
Qui est le CEO de ReNerve Ltd ?
Dr. Julian Chick est le Chief Executive Officer de ReNerve Ltd, il a rejoint l'entreprise depuis 2016.
Quelle est la performance du prix de l'action RNVEF ?
Le prix actuel de RNVEF est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de ReNerve Ltd ?
ReNerve Ltd appartient à l'industrie Health Care et le secteur est Health Care
Quelle est la capitalisation boursière de ReNerve Ltd ?
La capitalisation boursière actuelle de ReNerve Ltd est de $0
